Co-Diagnostics financials
$1.07−4.05%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $166.1K | $146.0K | $263.9K | $145.4K | $162.9K | $50.3K | $149.3K | $641.1K | $2.7M | $467.9K | $3.6M | $2.5M |
| Gross profit | $120.8K | -$47.8K | $121.5K | $119.1K | $130.8K | $28.7K | -$105.7K | $343.7K | $2.4M | $233.3K | $587.3K | $2.2M |
| Gross margin | 72.7% | −32.8% | 46.0% | 81.9% | 80.3% | 57.1% | −70.8% | 53.6% | 92.0% | 49.9% | 16.5% | 89.6% |
| Operating income | -$6.2M | -$9.2M | -$26.5M | -$7.0M | -$8.1M | -$8.6M | -$11.9M | -$10.2M | -$7.7M | -$10.3M | -$11.8M | -$8.9M |
| Net income | -$6.3M | -$9.1M | -$25.7M | -$5.9M | -$7.7M | -$7.5M | -$11.0M | -$9.7M | -$7.6M | -$9.3M | -$14.7M | -$6.0M |
| Net margin | −3782.4% | −6262.3% | −9755.1% | −4049.3% | −4745.0% | −14983.5% | −7387.4% | −1512.4% | −286.0% | −1990.4% | −412.8% | −243.5% |
| Diluted EPS | $-1.46 | $-4.06 | — | $-4.80 | $-7.00 | $-7.05 | $-10.72 | $-9.60 | $-7.50 | $-9.30 | $-14.95 | $-6.00 |
| EBITDA | -$6.0M | -$9.0M | -$7.4M | -$6.7M | -$7.8M | -$8.3M | -$11.9M | -$9.9M | -$7.3M | -$9.9M | -$11.5M | -$8.6M |
| Operating cash flow | -$7.2M | -$7.8M | -$6.2M | -$5.9M | -$8.3M | -$8.7M | -$8.2M | -$7.2M | -$5.2M | -$8.5M | -$4.8M | -$5.8M |
| Free cash flow | -$7.2M | -$8.0M | -$6.3M | -$6.0M | -$8.7M | -$8.8M | -$8.3M | -$7.4M | -$5.3M | -$8.9M | -$5.2M | -$6.0M |
| Diluted shares | 4.3M | 2.3M | — | 1.3M | 1.1M | 1.1M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $3.6M | $8.2M | $11.9M | $11.4M | $11.1M | $1.9M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $2.2M | $19.6M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $16.6M | $21.5M | $24.7M | $44.7M | $46.5M | $55.1M |
| Total liabilities | $3.9M | $5.5M | $4.1M | $4.9M | $5.3M | $7.2M |
| Shareholders' equity | $12.7M | $16.0M | $20.6M | $39.8M | $41.1M | $47.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology